Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
India’s Cipla has signed a memorandum of understanding with the Russian firm National Immunobiological Co. (Nacimbio) concerning the use of Cipla technology for Russian manufacturing of antiviral drugs to treat HIV and hepatitis C. Russia currently does not produce the treatments. Investment on the project will approach $45 million, Nacimbio says. Cipla is one of the world’s largest producers of HIV drugs.
This article has been sent to the following recipient: